Vestal Point Capital, LP Bausch Health Companies Inc. Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 250,000 shares of BHC stock, worth $1.59 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
250,000Holding current value
$1.59 Million% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
267Shares Held
252MCall Options Held
5.12MPut Options Held
9.42M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$221 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$175 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$168 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$98.1 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$82.7 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.3B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...